DEPYMED Trademark

Trademark Overview


On Thursday, May 26, 2022, a trademark application was filed for DEPYMED with the United States Patent and Trademark Office. The USPTO has given the DEPYMED trademark a serial number of 97430271. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, October 18, 2024. This trademark is owned by DepYmed Inc.. The DEPYMED trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of cancer, rare diseases, lung disorders and respiratory diseases, cardiovascular diseases, and other metabolic, inflammatory and central nervous system or neurodegenerative diseases

Pharmaceutical research and development; conducting early evaluations in the field of new pharmaceuticals
depymed

General Information


Serial Number97430271
Word MarkDEPYMED
Filing DateThursday, May 26, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateFriday, October 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations and therapeutic pharmaceuticals for the treatment of cancer, rare diseases, lung disorders and respiratory diseases, cardiovascular diseases, and other metabolic, inflammatory and central nervous system or neurodegenerative diseases
Goods and ServicesPharmaceutical research and development; conducting early evaluations in the field of new pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 2, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 2, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDepYmed Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFarmingdale, NY 11735

Party NameDepYmed Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFarmingdale, NY 11735

Trademark Events


Event DateEvent Description
Monday, May 30, 2022NEW APPLICATION ENTERED
Thursday, June 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 14, 2023ASSIGNED TO EXAMINER
Tuesday, March 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 9, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 9, 2023SOU EXTENSION 1 FILED
Wednesday, August 9, 2023SOU EXTENSION 1 GRANTED
Friday, October 18, 2024SOU TEAS EXTENSION RECEIVED
Friday, October 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 18, 2024SOU EXTENSION 3 GRANTED
Friday, October 18, 2024SOU EXTENSION 3 FILED
Tuesday, April 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 29, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 29, 2024SOU EXTENSION 2 FILED
Monday, April 29, 2024SOU EXTENSION 2 GRANTED